Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Short term Debt (2021 - 2023)

Historic Short term Debt for Silo Pharma (SILO) over the last 3 years, with Q1 2023 value amounting to $660279.0.

  • Silo Pharma's Short term Debt rose 91833.62% to $660279.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $660279.0, marking a year-over-year increase of 91833.62%. This contributed to the annual value of $364216.0 for FY2022, which is 1285.39% down from last year.
  • Latest data reveals that Silo Pharma reported Short term Debt of $660279.0 as of Q1 2023, which was up 91833.62% from $364216.0 recorded in Q4 2022.
  • Silo Pharma's 5-year Short term Debt high stood at $660279.0 for Q1 2023, and its period low was $2366.0 during Q1 2021.
  • For the 3-year period, Silo Pharma's Short term Debt averaged around $190123.1, with its median value being $72102.0 (2021).
  • Examining YoY changes over the last 5 years, Silo Pharma's Short term Debt showed a top increase of 264044.8% in 2022 and a maximum decrease of 7718.96% in 2022.
  • Over the past 3 years, Silo Pharma's Short term Debt (Quarter) stood at $417937.0 in 2021, then dropped by 12.85% to $364216.0 in 2022, then surged by 81.29% to $660279.0 in 2023.
  • Its Short term Debt was $660279.0 in Q1 2023, compared to $364216.0 in Q4 2022 and $16447.0 in Q3 2022.